Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- BrimonidineIndependent statistical analysis of Aqueous Humor Dynamics and Brimonidine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01144494).
- BRIUS Vs FFA Efficiency: Complete Statistical AnalysisIndependent statistical analysis of BRIUS Vs FFA Efficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04347018).
- BROADWAYIndependent statistical analysis of Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BROOKLYNIndependent statistical analysis of Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01091454).
- BRPIndependent statistical analysis of IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BrUOG 390: Neoadjuvant Treatment With Talazoparib: Complete Statistical AnalysisIndependent statistical analysis of BrUOG 390: Neoadjuvant Treatment With Talazoparib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04598321).
- BRUOG-407Independent statistical analysis of Removing Transfusion Dependence as a Barrier to Hospice Enrollment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05063591).
- Bryostatin Treatment of Moderately Severe Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Bryostatin Treatment of Moderately Severe Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04538066).
- BSSIndependent statistical analysis of Blue Sky Study: Impact of Milk and Vitamin D for Child Growth and Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- BT063 in SLEIndependent statistical analysis of Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02554019).
- BTMSIndependent statistical analysis of Measuring Plasticity in SFC/dACC Following Theta-Burst-Stimulation Using TMS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03946059).
- BTX-A Treatment for Palmar Hyperhidrosis: Complete Statistical AnalysisIndependent statistical analysis of BTX-A Treatment for Palmar Hyperhidrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01262339).
- BTX-A-HAC NGIndependent statistical analysis of Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Bubble PEP Training Among Patient With Chronic Obstructive Pulmonary Disease in Pulmonary Function Effects: Complete Statistical AnalysisIndependent statistical analysis of Bubble PEP Training Among Patient With Chronic Obstructive Pulmonary Disease in Pulmonary Function Effects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage: Complete Statistical AnalysisIndependent statistical analysis of Buccal Misoprostol During Cesarean Section for Preventing Postpartum Hemorrhage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01733329).
- Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor: Complete Statistical AnalysisIndependent statistical analysis of Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01519765).
- BudERIndependent statistical analysis of Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis: Complete Statistical AnalysisIndependent statistical analysis of Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Building Resiliency in Patients Admitted to the Neuroscience Intensive Care Unit and Their Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Building Resiliency in Patients Admitted to the Neuroscience Intensive Care Unit and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY): Complete Statistical AnalysisIndependent statistical analysis of Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03615469).
- BULLETIndependent statistical analysis of BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860311).
- Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis: Complete Statistical AnalysisIndependent statistical analysis of Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01157169).
- Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03113409).
- Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04995029).
- Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00555425).
- Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Buspirone for Functional Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Buspirone for Functional Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02674412).
- Busulfan and Cyclophosphamide Followed By ALLO BMT: Complete Statistical AnalysisIndependent statistical analysis of Busulfan and Cyclophosphamide Followed By ALLO BMT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01685411).
- Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide: Complete Statistical AnalysisIndependent statistical analysis of Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00800839).
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643668).
- BUTTERFLEYEIndependent statistical analysis of Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity: primary endpoint results, effect estimate with confidence…
- Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00919100).
- BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03264131).
- BWIndependent statistical analysis of Enhancing BodyWorks: A Canine Health Literacy Module: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04516252).
- BWP-ADIndependent statistical analysis of Enhancing Consent for Alzheimer's Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00453544).
- BWSP3Independent statistical analysis of Black Widow Spider Antivenin for Patients With Systemic Latrodectism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00657540).
- C_ASCENTIndependent statistical analysis of Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- C-CADIndependent statistical analysis of Community-Based Communication Approaches for Blood Donation in Ghana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04783077).
- C-earlyIndependent statistical analysis of A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve…
- C-OPTIMISEIndependent statistical analysis of Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- C-PRECISE-01Independent statistical analysis of MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495621).
- C-Pulse IDE Feasibility Study- A Heart Assist System: Complete Statistical AnalysisIndependent statistical analysis of C-Pulse IDE Feasibility Study- A Heart Assist System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00815880).